Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to -$40.0 million.

  • Eton Pharmaceuticals' Cash from Investing Activities was N/A to -$284,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.1 million, marking a year-over-year change of. This contributed to the annual value of -$40.0 million for FY2024, which is 5063.10% down from last year.
  • As of FY2024, Eton Pharmaceuticals' Cash from Investing Activities stood at -$40.0 million, which was down 5,063.10% from -$775,000 recorded in FY2023.
  • Eton Pharmaceuticals' Cash from Investing Activities' 5-year high stood at -$50,000 during FY2020, with a 5-year trough of -$40.0 million in FY2024.
  • For the 3-year period, Eton Pharmaceuticals' Cash from Investing Activities averaged around -$14.5 million, with its median value being -$2.8 million (2022).
  • As far as peak fluctuations go, Eton Pharmaceuticals' Cash from Investing Activities soared by 97.29% in 2020, and later crashed by 5,063.10% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Cash from Investing Activities stood at -$50,000 in 2020, then slumped by 5,018.00% to -$2.6 million in 2021, then fell by 8.95% to -$2.8 million in 2022, then skyrocketed by 72.20% to -$775,000 in 2023, then crashed by 5,063.10% to -$40.0 million in 2024.